NCT07179614 Kentucky Women's Justice Community Overdose Innovation Network - Phase II
| NCT ID | NCT07179614 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Michele Staton |
| Condition | Overdose Risk |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2026-06-23 |
| Primary Completion | 2030-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2026-06-23 with a primary completion date of 2030-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project continues our work with women in the Kentucky Women's Justice Community Overdose Innovation Network Phase II (WJCOIN-II) with the overall aim of reducing overdose risk during the transition from jail to rural communities. WJCOIN-II has potential for significant impact regarding the effectiveness, implementation, and sustainability of innovative overdose prevention strategies during the high-risk time of community re-entry among vulnerable, CLS-involved women in rural communities. This research will impact the field by increasing the capacity of the criminal legal system to respond to the overdose crisis through increased access to prevention strategies to reduce overdose risk.
Eligibility Criteria
Inclusion Criteria: * DSM-5 scores of 2+ for opioids (OUD) and/or stimulants (StUD), * no evidence of cognitive impairment in providing consent, * a release date within 7-60 days to allow for time for intervention sessions, * willingness to consider SUD treatment post-release, and * willingness to provide the name and contact information of at least one person in the community who will support the woman's recovery pre/post-release (SP). Exclusion Criteria: * Not living in a rural area * Any condition that would not allow capable informed consent
Contact & Investigator
Michele Staton, PhD
PRINCIPAL INVESTIGATOR
University of Kentucky
Frequently Asked Questions
Who can join the NCT07179614 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Overdose Risk. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07179614 currently recruiting?
Yes, NCT07179614 is actively recruiting participants. Contact the research team at mstaton@uky.edu for enrollment information.
Where is the NCT07179614 trial being conducted?
This trial is being conducted at Harlan, United States.
Who is sponsoring the NCT07179614 clinical trial?
NCT07179614 is sponsored by Michele Staton. The principal investigator is Michele Staton, PhD at University of Kentucky. The trial plans to enroll 300 participants.